1Futterweit W. Polycystic ovary syndrome: clinical perspectives and management. Obstet Gynecol Surv, 1999, 54(6):403-13.
2Diamanti-Kandarakis E & Kandarakis HA. Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome. Ann N Y Acad Sci, 2003, 997(11 ):322-9.
3Waterworth DM, Bennett ST, Gharani N. et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet, 1997, 349(9 067):1771-2.
4Michelmore K, Ong K, Mason S, et al. Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf), 2001, 55(4):439-46.
5Moore GE, Abu-Amero SN, Bell G, et al. Evidence, that insulin is imprinted in the human yolk sac.Diabetes,2001,50:199-203.
6Calvo RM, Telleria D, Sancho J, et al. Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril, 2002, 77(4):666-8.
7Vankova M, Vrbikova J, Hill M, et al. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome.Ann N Y Acad Sci, 2002, 967(6):558-65.
8Powell BL, Haddad L, Bennett A, et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovarysy ndrome or related traits. J Clin Endocrinol Metab, 2005, 90(5):2 988-93.
9Tucci S, Futterweit W, Concepcion ES, et al. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab, 2001, 86(1 ):446-9.
2Ortega-Gonzalez C, Cardoza L, Coutino B, et al. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome. J Endocrinol, 2005,184:233-239.
3Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab, 2001,28:392-399.
4Talbot JA, Bicknell BJ, Rajkhowa M, et al. Molecular scanning of the insulin receptor gene in women with polycystic ovary syndrome. J Clin Endocrinol Metab,1996,81: 1979-1983.
5Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med, 2000,132: 989-993.
6Jahnfar S, Eden JA, Warren P, et al. A twin study of polycystic ovary syndrome. Fertil Steril,1995,63: 478-486.
7Urbanek M, Legro RS, Driscoll D, et al. Searching for the polycystic ovary syndrome genes. J Pediatr Endocrinol Metab, 2000,13 Suppl 5:1311-1313.
8Siegel S, Futterweit W,Terry F, et al. A C/T single nusleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril, 2002,78: 1240-1243.
9Morales AJ,Laughin GA,Butzow T, et al. Insulin, somatotropic, and luterinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab, 1996,81:2854-2864.
10Patel K,Coffler MS,Dahan MH,et al.Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.Clin Endocrinol (Oxf),2004,60:67-74.
